Medicus Pharma Ltd.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 |
|---|---|---|---|
| Operating income | -$34.4M | -$11.2M | -$4.7M |
| Operating expenses | $34.4M | $11.2M | $4.7M |
| Cash from operations | -$22.8M | -$10.2M | -$4.2M |
| Total assets | $10.1M | $5.6M | $1.9M |
| Total liabilities | $10.0M | $2.5M | $781,609 |
Shares outstanding 56.7M · Free float 86.1%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.